Brevicon · DIN 02187094 · 0.035 mg & 0.5 mg · tablets, 28-pack
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Brevicon · DIN 02187094
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2006-04-18 · brand BREVICON 0.5/35 TABLETS (28-DAY PACK) · ATC G03AA05 NORETHISTERONE AND ESTROGEN · form Tablet · route Oral · ingredients ETHINYL ESTRADIOL .035 MG, NORETHINDRONE .5 MG · company Pfizer canada ulc · schedule Prescription
Brevicon: Formulary list price $16.45 per unit (the source does not state the unit; exact figure $16.4500). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02187094)
Source record
DIN 02187094: Brevicon
Raw flags: sec3=Y
Item: 683200050; group id 798; item number 1949; lccId None; manufacturer id PFI
Source form: Tab-28 Pk; strength: 0.035mg & 0.5mg
Recorded listing: General benefit
Source prices (unrounded): $16.4500; ministry $16.4500
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02187094
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=42888
Shortage status: not checked (no credentials)